10 Stocks with Strong BUY Signals for September 2026

OpportunityRadar Uncovers 10 Stocks with Robust BUY Signals for September

As September 2026 begins, the latest OpportunityRadar scan highlights a compelling set of BUY signals across various market segments, with Appian Corporation (APPN) standing out for its exceptional recent performance. APPN registered an impressive 39.56% return over the last month and a staggering 64.96% over three months, all while securing an 83% confidence rating and a 'STRONG ENTRY' signal. Microsoft Corporation (MSFT) leads the overall OpportunityRadar Score at 75, underpinned by a high fundamental score of 90, suggesting underlying strength despite a 'BUY' signal with 67% confidence.

The current scan reveals a significant number of high-conviction opportunities. Four of the top ten tickers — Immunocore Holdings plc (IMCR), Arbutus Biopharma Corporation (ABUS), Merck & Company, Inc. (MRK), and Scholar Rock Holding Corporation (SRRK) — boast a perfect 100% confidence rating coupled with a 'STRONG ENTRY' signal. The average Relative Strength Index (RSI) for these ten tickers sits at approximately 60.36, indicating generally healthy price momentum without being broadly overextended. Furthermore, seven out of these ten tickers are currently exhibiting a MACD BULL signal, suggesting positive short-term momentum for the majority.

Top 10 Signals at a Glance

#1: MSFT — Microsoft Corporation

Microsoft Corporation (MSFT) registers the highest overall OpportunityRadar Score in this scan, reaching 75. This score is notably bolstered by a robust fundamental component of 90, suggesting significant underlying financial strength. Despite this, the technical component stands at 65, and the signal confidence is 67%, indicating a 'BUY' signal with a standard 'ENTRY' recommendation rather than a 'STRONG ENTRY'. The stock's current price is $494.78. Its RSI is 59.5, reflecting moderate momentum, but the MACD indicator is currently in BEAR territory, which presents a mixed technical picture. Over the past month, MSFT has seen a modest return of 1.5%, while its three-month return is a more substantial 15.59%.

A point of consideration for MSFT is its Risk/Reward ratio of 0.9. This suggests that the potential upside may be slightly less than the inherent risk, according to the OpportunityRadar methodology. The MACD BEAR signal, despite the overall BUY signal and strong fundamental score, also warrants attention as a divergence in technical indicators.

#2: RACE — Ferrari N.V.

Ferrari N.V. (RACE) presents a 'BUY' signal with an impressive 83% confidence rating and a 'STRONG ENTRY' recommendation at its current price of $413.74. The OpportunityRadar Score for RACE is 65, with a strong technical component of 70, indicating favorable price action. However, its fundamental score is 58, which is lower than its technical counterpart. The stock's RSI is 53.5, suggesting balanced momentum, but similar to MSFT, the MACD indicator is in BEAR territory. This indicates that while the overall signal is strong, some short-term momentum aspects are not fully aligned.

RACE has delivered a 2.72% return over the last month and a robust 20.13% over the past three months, demonstrating consistent upward movement. The Risk/Reward ratio for RACE is 1.1, implying a slightly favorable potential upside relative to risk. The conflicting MACD BEAR signal, however, is a technical detail to monitor, even with the high confidence and 'STRONG ENTRY' rating.

#3: IMCR — Immunocore Holdings plc

Immunocore Holdings plc (IMCR) is highlighted by a perfect 100% confidence rating and a 'STRONG ENTRY' signal, making it a high-conviction opportunity. The stock, priced at $36.78, holds an OpportunityRadar Score of 64, with a technical score of 71 and a fundamental score of 53. Its technical indicators are largely aligned, with an RSI of 60.8 and a MACD in BULL territory, affirming positive momentum. IMCR has shown strong recent performance, with a 1-month return of 10.65% and an even more significant 3-month return of 28.38%, indicating a clear upward trend.

Despite the strong signals and impressive returns, a key risk factor for IMCR is its Risk/Reward ratio, which stands at a low 0.3. This suggests that the potential reward may be considerably smaller than the inherent risk, based on OpportunityRadar's assessment. Investors should weigh this ratio against the high confidence and strong technical alignment.

#4: ABUS — Arbutus Biopharma Corporation

Arbutus Biopharma Corporation (ABUS), trading at $5.14, also garners a 100% confidence rating and a 'STRONG ENTRY' signal from OpportunityRadar. Its overall score is 64, with a technical score of 71 and a fundamental score of 53, mirroring the breakdown seen in IMCR. The technical picture for ABUS is robust, featuring an RSI of 62.5 and a MACD firmly in BULL territory, indicating strong positive momentum. The stock has experienced substantial gains, with a 1-month return of 16.29% and a 3-month return of 18.16%, reflecting a consistent upward trajectory.

Similar to IMCR, the primary risk indicator for ABUS is its low Risk/Reward ratio of 0.6. While higher than IMCR's, it still suggests that the potential reward might be less than the associated risk. This factor should be carefully considered alongside the otherwise highly confident and technically strong 'BUY' signal.

#5: APPN — Appian Corporation

Appian Corporation (APPN) stands out with exceptional price performance, posting a 39.56% return over the last month and an impressive 64.96% over the past three months. The stock, priced at $39.71, receives a 'BUY' signal with 83% confidence and a 'STRONG ENTRY' recommendation. APPN's OpportunityRadar Score is 63, composed of a technical score of 68 and a fundamental score of 56. The technical indicators are supportive, with an RSI of 63.7 and a MACD in BULL territory, confirming the strong upward momentum observed in its returns.

The Risk/Reward ratio for APPN is 1.1, indicating a favorable balance where potential reward slightly outweighs risk. While the recent surge in price is notable, the high velocity of these gains and the RSI of 63.7, while not overbought, suggest that monitoring for potential consolidation or pullback after such a strong run would be prudent, even with the 'STRONG ENTRY' signal.

#6: MRK — Merck & Company, Inc.

Merck & Company, Inc. (MRK) is another high-conviction pick, receiving a 'BUY' signal with a 100% confidence rating and a 'STRONG ENTRY' recommendation. The stock is currently trading at $150.70 and holds an OpportunityRadar Score of 63, with a technical score of 68 and a fundamental score of 55. Its technical strength is evident with an RSI of 64.5 and a MACD in BULL territory, signaling positive price momentum. MRK has demonstrated strong recent performance, with a 1-month return of 17.73% and a 3-month return of 31.39%, indicating a robust trend.

Despite the perfect confidence and strong technicals, MRK's Risk/Reward ratio is 0.4. This low ratio suggests that the potential reward for taking on this position is significantly less than the associated risk, according to the OpportunityRadar assessment. This numerical aspect warrants careful consideration for potential investors.

#7: SRRK — Scholar Rock Holding Corporation

Scholar Rock Holding Corporation (SRRK) also features a 100% confidence rating and a 'STRONG ENTRY' signal, trading at $56.20. Its OpportunityRadar Score is 63, with a technical score of 67 and a fundamental score of 56. The technical setup is favorable, with an RSI of 55.5 and a MACD in BULL territory, indicating a healthy and positive momentum trend. SRRK has delivered strong returns, with a 1-month gain of 17.6% and a 3-month gain of 25.9%, showcasing consistent upward price action over the medium term.

The Risk/Reward ratio for SRRK is 1.0, suggesting an equal balance between potential reward and risk. While this is a neutral reading, it does not offer a significant edge in terms of risk-adjusted returns compared to tickers with higher R/R ratios. Investors should consider this balance in conjunction with the strong confidence and technical indicators.

#8: VEEV — Veeva Systems Inc.

Veeva Systems Inc. (VEEV), priced at $278.24, shows a 'BUY' signal with a lower confidence rating of 50% and a 'PARTIAL ENTRY' recommendation. Its OpportunityRadar Score is 62, comprising a technical score of 64 and a fundamental score of 58. VEEV's technical indicators include a MACD in BULL territory, confirming some positive momentum. However, its RSI is notably high at 73.7, approaching the traditionally overbought threshold of 70, which could suggest a potential for consolidation or pullback in the near term.

VEEV has posted significant returns, with a 31.33% gain over the last month and a 55.69% gain over three months. Despite this strong performance, the low 50% confidence and 'PARTIAL ENTRY' signal, combined with the elevated RSI, indicate a more cautious outlook from OpportunityRadar. The Risk/Reward ratio is 0.6, further highlighting a less favorable risk-adjusted profile.

#9: TRGP — Targa Resources, Inc.

Targa Resources, Inc. (TRGP), trading at $296.12, receives a 'BUY' signal with 83% confidence and a 'STRONG ENTRY' recommendation. The stock's OpportunityRadar Score is 62, with a technical score of 64 and a fundamental score of 58. Technical indicators are positive, with an RSI of 60.0 and a MACD in BULL territory, suggesting healthy upward momentum. TRGP has delivered a 1-month return of 12.6% and a 3-month return of 12.73%, indicating steady, albeit less explosive, gains compared to some other tickers on the list.

A notable aspect for TRGP is its Risk/Reward ratio of 0.4. This low ratio suggests that the potential reward is significantly less than the associated risk, according to the OpportunityRadar assessment. While the confidence and technicals are strong, this risk metric warrants close attention for potential investors.

#10: NRIX — Nurix Therapeutics, Inc.

Nurix Therapeutics, Inc. (NRIX), priced at $25.60, shows a 'BUY' signal with a 67% confidence rating and an 'ENTRY' recommendation. Its OpportunityRadar Score is 62, with a technical score of 68 and a fundamental score of 53. The stock's RSI is 49.9, indicating neutral momentum, and its MACD is in BEAR territory, suggesting a lack of strong positive short-term momentum. While its 1-month return is a modest 3.69%, NRIX has achieved an impressive 65.37% return over the past three months, indicating a strong longer-term trend.

NRIX stands out with the highest Risk/Reward ratio among the top ten tickers at 1.6, suggesting a favorable potential upside relative to risk. However, this positive ratio must be weighed against its MACD BEAR signal and the standard 'ENTRY' recommendation, which reflects a lower confidence level compared to 'STRONG ENTRY' signals. The divergence between strong 3-month returns and current MACD BEAR status is a key factor to monitor.

Key Observations Across the Scan

• High Conviction Signals: Four of the ten profiled tickers – IMCR, ABUS, MRK, and SRRK – currently display a 100% confidence rating with a 'STRONG ENTRY' signal, indicating a high degree of alignment across OpportunityRadar's criteria.
• Positive Momentum: Seven of the ten tickers (IMCR, ABUS, APPN, MRK, SRRK, VEEV, TRGP) are showing a MACD BULL signal, suggesting prevailing positive short-term price momentum for the majority.
• Strong Recent Returns: Seven tickers recorded 1-month returns exceeding 10%, with Appian Corporation (APPN) leading significantly at 39.56% and Veeva Systems Inc. (VEEV) following at 31.33%. All ten tickers exhibited positive 3-month returns, reinforcing a generally upward trend across the selection.
• Average RSI: The average RSI across these ten tickers is approximately 60.36, suggesting that while momentum is present, most are not yet in extreme overbought conditions, with the exception of VEEV.

Key Risk Factors

• MACD Divergence: Three tickers – Microsoft Corporation (MSFT), Ferrari N.V. (RACE), and Nurix Therapeutics, Inc. (NRIX) – currently show a MACD BEAR signal despite receiving overall 'BUY' signals. This divergence between the comprehensive signal and a key momentum indicator warrants careful monitoring.
• Elevated RSI: Veeva Systems Inc. (VEEV) presents an RSI of 73.7. While VEEV has demonstrated strong recent performance, an RSI above 70 typically indicates that a stock is entering overbought territory, suggesting increased potential for a short-term pullback or consolidation.
• Low Risk/Reward Ratios: Several tickers, including Immunocore Holdings plc (IMCR) at 0.3, Merck & Company, Inc. (MRK) at 0.4, Targa Resources, Inc. (TRGP) at 0.4, and Microsoft Corporation (MSFT) at 0.9, exhibit Risk/Reward ratios below 1.0. This suggests that the potential upside from the current price may be less than the identified downside risk, according to OpportunityRadar's assessment.

About Our Methodology

OpportunityRadar scans 6,600+ US stocks daily using 15+ technical indicators including RSI, MACD, Bollinger Bands, ADX, Aroon, support/resistance levels, and volume analysis, combined with fundamental metrics. Stocks are scored 0-100 with signals ranging from Accumulate to Strong Buy. Entry confidence is rated 50-100% based on 6 confirmation factors.

Disclaimer: This article is for informational purposes only and does not constitute financial advice. Past performance does not guarantee future results. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Data as of September 02, 2026.